High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
Titel:
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
Auteur:
Holtzman, Noa G. Curtis, Lauren M. Salit, Rachel B. Shaffer, Brian C. Pirsl, Filip Ostojic, Alen Steinberg, Seth M. Schulz, Eduard Wilder, Jennifer S. Hughes, Thomas E. Rose, Jeremy Memon, Sarfraz Korngold, Robert Gea-Banacloche, Juan C. Fowler, Daniel H. Hakim, Frances T. Gress, Ronald E. Bishop, Michael R. Pavletic, Steven Z.